Hostname: page-component-848d4c4894-5nwft Total loading time: 0 Render date: 2024-06-10T09:53:15.587Z Has data issue: false hasContentIssue false
  • English
  • Français

Focus on Women's Mental Health

Published online by Cambridge University Press:  01 February 2011

Susan G. Kornstein  and
Anita H. Clayton
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Guest Editors Note
Information
CNS Spectrums , Volume 16 , Issue 2 , February 2011 , pp. 27
Copyright
Copyright © Cambridge University Press 2012

Footnotes

Faculty Disclosures: Dr. Kornstein has been a consultant to Bristol-Myers Squibb, Dey Pharma, Eli Lilly, PGxhealth, Pfizer, Rexahn, and Takeda; has received research support from Boehringer-Ingelheim, Bristol-Myers Squibb, Eli Lilly, Forest Laboratories, the National Institute of Mental Health, Novartis, Otsuka, Pfizer, and Takeda; and has received book royalties from Guilford Press.Dr. Clayton has been a consultant to and/or on the advisory boards of AstraZeneca, Boehringer-Ingelheim, Bristol-Myers Squibb, Eli Lilly, New England Research Institutes, Pfizer, PGxHealth, sanofi-aventis and Takeda; has received grant support from BioSante, Boehringer-Ingelheim, Pfizer, and Repligen Corporation; and receives royalties from Ballantine Books/Random House; Guilford Publications; the Changes in Sexual Functioning Questionnaire; and Healthcare Technology Systems, Inc.

References

Faculty Disclosures: Dr. Kornstein has been a consultant to Bristol-Myers Squibb, Dey Pharma, Eli Lilly, PGxhealth, Pfizer, Rexahn, and Takeda; has received research support from Boehringer-Ingelheim, Bristol-Myers Squibb, Eli Lilly, Forest Laboratories, the National Institute of Mental Health, Novartis, Otsuka, Pfizer, and Takeda; and has received book royalties from Guilford Press.Dr. Clayton has been a consultant to and/or on the advisory boards of AstraZeneca, Boehringer-Ingelheim, Bristol-Myers Squibb, Eli Lilly, New England Research Institutes, Pfizer, PGxHealth, sanofi-aventis and Takeda; has received grant support from BioSante, Boehringer-Ingelheim, Pfizer, and Repligen Corporation; and receives royalties from Ballantine Books/Random House; Guilford Publications; the Changes in Sexual Functioning Questionnaire; and Healthcare Technology Systems, Inc.